Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence

• Status: Completed
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The study was conducted between 2004 and 2006 to prove efficacy and tolerability of the antimuscarinic propiverine compared to placebo in children suffering from non-neurogenic overactive bladder and urinary incontinence.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: APOGEPHA Arzneimittel GmbH
• Treatments: Propiverine

Criteria

Inclusion Criteria:

• voiding frequency 8 or above per day

• at least one incontinence episode per day

• age between 5-10 years

• body weight between 17 and 45 kg

Exclusion Criteria:

• normal age expected bladder capacity

• PVR more than 10 ml

• dysfunctional voiding

• neurogenic disorders

• UTI, constipation